Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!
RUEN
Разместить новость

Statin use linked to risk for cataracts

29.12.20141662
Patients treated with statins for CVD prevention were more likely than nonusers to develop cataracts requiring surgical treatment, researchers reported in the Canadian Journal of Cardiology.

New Year's congratulations by RSC President Evgeny Shlyakhto

25.12.20142426
On behalf of the Russian Society of Cardiology Board please accept congratulations on coming Christmas and New Year – the year of fighting cardiovascular diseases in Russia!

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study

25.12.20141727
The long-term outcome of atrial fibrillation (AF) ablation demonstrates attrition. This outcome may be due to failure to attenuate the progressive substrate promoted by cardiovascular risk factors.

Certain Antibiotic/Statin Combos May Be Unsafe Mix: Study

24.12.20141916
Seniors who take the antibiotic Biaxin (clarithromycin) along with certain types of cholesterol-lowering statins are at risk for drug interaction side effects that can lead to hospitalization or even death, a new study suggests.

The International Society of Hypertension offers entirely free Research Fellowships

24.12.20141720
Это замечательная возможность для молодых ученых и клиницистов, получающих ученую степень и стремящихся улучшить свое резюме, а также получить все преимущества от новой сети ISH New Investigator Network (ISHNIN).

Survival rates higher in obese patients with HF

23.12.20142289
Patients who were overweight or obese before diagnosis of HF had better survival rates after HF diagnosis compared with normal-weight patients with HF.

New trial will assess dabigatran for prevention of recurrent stroke

22.12.20141882
The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke of undetermined source, according to a press release from Boehringer Ingelheim.
123...225226227228229...363364365
Enter the Society
Subscribe to Newsletter
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.